Ventas, Inc. $VTR Stake Decreased by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. reduced its holdings in shares of Ventas, Inc. (NYSE:VTR) by 13.2% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 108,467 shares of the real estate investment trust’s stock after selling 16,465 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Ventas were worth $9,222,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently modified their holdings of VTR. Tred Avon Family Wealth LLC raised its holdings in shares of Ventas by 25.1% during the third quarter. Tred Avon Family Wealth LLC now owns 9,889 shares of the real estate investment trust’s stock valued at $841,000 after purchasing an additional 1,986 shares during the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd lifted its position in Ventas by 10.7% during the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 203,964 shares of the real estate investment trust’s stock valued at $17,341,000 after purchasing an additional 19,741 shares during the period. Family Wealth Partners LLC lifted its position in Ventas by 2.9% during the third quarter. Family Wealth Partners LLC now owns 10,322 shares of the real estate investment trust’s stock valued at $878,000 after purchasing an additional 288 shares during the period. CWA Asset Management Group LLC bought a new position in Ventas during the third quarter valued at approximately $212,000. Finally, SteelPeak Wealth LLC purchased a new stake in Ventas in the third quarter worth approximately $3,075,000. 94.18% of the stock is owned by hedge funds and other institutional investors.

Ventas Price Performance

Shares of NYSE:VTR opened at $86.86 on Friday. The firm’s 50 day moving average price is $87.89 and its 200-day moving average price is $88.06. Ventas, Inc. has a twelve month low of $68.15 and a twelve month high of $101.60. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86. The stock has a market capitalization of $44.55 billion, a PE ratio of 160.85, a price-to-earnings-growth ratio of 3.39 and a beta of 0.72.

Ventas (NYSE:VTR) last posted its quarterly earnings data on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.96 by $0.01. The company had revenue of $1.73 billion for the quarter, compared to the consensus estimate of $1.68 billion. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The firm’s revenue was up 21.7% compared to the same quarter last year. During the same quarter last year, the firm posted $0.87 earnings per share. Equities research analysts expect that Ventas, Inc. will post 3.89 EPS for the current year.

Ventas Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, October 15th. Stockholders of record on Wednesday, September 30th were given a dividend of $0.52 per share. The ex-dividend date of this dividend was Wednesday, September 30th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. Ventas’s payout ratio is presently 385.19%.

Analysts Set New Price Targets

A number of equities research analysts have commented on the stock. Cantor Fitzgerald lifted their target price on shares of Ventas from $97.00 to $102.00 and gave the stock an “overweight” rating in a research report on Friday, July 31st. Citigroup increased their price target on Ventas from $100.00 to $110.00 and gave the company a “buy” rating in a report on Tuesday, August 4th. Barclays lowered their price target on Ventas from $102.00 to $91.00 and set an “equal weight” rating on the stock in a report on Tuesday, October 13th. BNP Paribas Exane raised their price target on Ventas from $93.00 to $110.00 and gave the stock an “outperform” rating in a research note on Thursday, July 30th. Finally, Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Ventas in a report on Monday, October 19th. Eighteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, Ventas presently has an average rating of “Moderate Buy” and an average target price of $98.91.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust focused on healthcare and senior housing properties. The company owns, manages and develops a diversified portfolio of healthcare-related real estate, including senior living communities, medical office buildings, life science and innovation centers, and other properties serving healthcare providers and institutions.

Ventas generally leases its properties to healthcare operators, physicians, health systems, universities and research organizations.